jeudi 22 juillet 2021

Tulane spin-out company awarded grant to develop new graft for treating pelvic organ prolapse

The Eunice Kennedy Shriver National Institute of Child Health & Human Development has awarded a $256,000 grant to BioAesthetics Corp., a Tulane University spin-out company, to develop a new graft for treating pelvic organ prolapse (POP). Tulane spin-out company awarded grant to develop new graft for treating pelvic organ prolapse

Aucun commentaire:

Enregistrer un commentaire